Chelation therapy in beta-thalassemia major. I. Intravenous and subcutaneous deferoxamine.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000983:Antipyrine / Q000378:metabolism; D002648:Child; D002675:Child, Preschool; D003676:Deferoxamine / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005293:Ferritins / Q000097:blood; D006801:Humans; D007263:Infusions, Parenteral; D007501:Iron / Q000652:urine; D013789:Thalassemia / Q000188:drug therapy* / Q000652:urine
D005293:Ferritins; D007501:Iron; D003676:Deferoxamine; D000983:Antipyrine